Section Arrow
Quote
BHVN.NYSE
- Biohaven Ltd
Quotes are at least 15-min delayed:2025/07/21 06:42 EDT
Pre Market
Last
 14.03
-0.02 (-0.14%)
Bid
13.92
Ask
14.2
High 14.05 
Low 14 
Volume 87 
Regular Hours
Last
 14.05
-1.06 (-7.02%)
Day High 
15.34 
Prev. Close
15.11 
1-M High
15.37 
Volume 
1.88M 
Bid
13.92
Ask
14.2
Day Low
13.97 
Open
15.2 
1-M Low
13.04 
Market Cap 
1.54B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.17 
20-SMA 14.29 
50-SMA 15.72 
52-W High 55.7 
52-W Low 13.04 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-9.25/-5.92
Enterprise Value
1.58B
Balance Sheet
Book Value Per Share
2.54
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
Pre Market 2 -0.28 -12.28%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
Pre Market 13.13 -0.945 -6.71%
NCNANuCana plc0.0477+0.0009+1.92%-- 
Pre Market 0.0474 -0.0003 -0.63%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
Pre Market 6.22 +0.38 +6.51%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Pre Market 6.06 +0.14 +2.36%
Quotes are at least 15-min delayed：2025/07/21 06:42 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.